SEC Form 4 · accession 0001437749-18-010288
ZEVRA THERAPEUTICS, INC. · ZVRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel L Cohen
Officer — EVP, Govt. & Public Relations
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 9:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2018 | P | 5,500 | $6.4455 | A | 35,500 | D | |
| Common StockF1 | May 15, 2018 | P | 2,000 | $6.4455 | A | 2,000 | D | |
| Common StockF2 | May 15, 2018 | P | 200 | $6.45 | A | 1,450 | I | By Daughter. |
| Common StockF3 | May 15, 2018 | P | 200 | $6.45 | A | 1,450 | I | By Daughter. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Held jointly with spouse.
- F2The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares.
- F3The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares.